going off glp 1 People Who Go GLP-1s Are Experiencing a Sudden and Terrible Hunger Two Years After Stopping GLP-1s,
Description
15:45 - The "Bitter Brake" Theory: Location Matters Dr

Nefs G, Pouwer F, Denollet J, Kramer H, Wijnands - van Gent CJM, Pop VJM

By HPLC]

Aug 14: In what is expected to become a multibillion-dollar blockbuster, Pfizers BCMAxCD3 bispecific antibody Elrexfio (elranatamab-bcmm) has secured an FDA accelerated approval as another off-the-shelf treatment option for patients with relapsed or refractory multiple myeloma (RRMM) who have received at least four prior lines of therapy
All GLP-1 RAs other than Saxenda and Wegovy have the indication of T2DM and are subsidized only for patients with T2DM who first tried metformin, sulphonylureas or insulin, or where these are not appropriate

doi: 10.1016/j.regpep.2004.08.026
